Ergoteles’s Halozyme HALO Stock Holding History

Ergoteles’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-21,664	Closed	-$781K	–	390
2023 Q2	$781K	Sell	21,664 -15,268	-41%	-$521K	0.04%	528
2023 Q1	$1.41M	Buy	36,932 +29,606	+404%	+$1.39M	0.06%	380
2022 Q4	$417K	Buy	+7,326	New	+$375K	0.02%	775
2022 Q1	–	Sell	-25,830	Closed	-$1.04M	–	1381
2021 Q4	$1.04M	Buy	+25,830	New	+$964K	0.04%	409
2021 Q2	–	Sell	-23,600	Closed	-$984K	–	1567
2021 Q1	$984K	Buy	+23,600	New	+$1.08M	0.03%	380
2020 Q4	–	Sell	-8,300	Closed	-$218K	–	768
2020 Q3	$218K	Buy	+8,300	New	+$231K	0.03%	447

Other funds holding HALO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SCM

Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Ergoteles's HALO Position: Q3 2023 in Review

Ergoteles sold out of Halozyme (HALO) in Q3 2023, closing a stake of 21,664 shares — an estimated $781K sold.

Ergoteles first reported a position in HALO in Q3 2020 and held it in 6 quarters. The position peaked at $1.41M in Q1 2023. 389 funds tracked by Wall St. Rank hold HALO as of Q3 2023.

Ergoteles reported no remaining Halozyme position as of Q3 2023 after selling out during the quarter.
Ergoteles sold 21,664 Halozyme shares in Q3 2023, an estimated $781K.
Ergoteles first reported a position in Halozyme in Q3 2020 and held it in 6 quarters.
Ergoteles's Halozyme position peaked at $1.41M in Q1 2023.
389 funds tracked by Wall St. Rank held Halozyme as of Q3 2023.

Based on Ergoteles's 13F filing for Q3 2023, filed 14 Nov 2023.